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Objectives. The purpose of this study was to determine the 
test-retest stability of echocardiography for tirti measurement of 
left ventricular mass and function in patients with hypertension. 
Background. De&&nation of changes in left ventricular mass 
may be impaired by study variability. The amount by which 
variables of mass and left ventricular function must change in an 
individual patient to exceed tempclral variability has not been 
determined in a multicenter trial. 
Results. Despite excellent reliability (intraclass coefficient of 
Methods. Ninety-six patients with hypertension had two- 
dimensional targeted, M-mode Doppler echocardiography re- 
peated at 6 + 8 days by the same technician utilizing the same 
machine. Left ventricular mass aud variables of systolic and 
diastolic function were measured. Test-retest reliability and the 
width of the 95% confidence intervals of variable change, as well as 
the contributions of age, study quality and body size to measure- 
ment reliability, were determined. 
-- 
Ir. clinical trials, echocardiography has demonstrated the effi- 
cacy of antihypertensive drugs a .cl nondrug therapy in reduc- 
ing left ventricular mass (1-Q an important predictor of 
morbidity and mortality (6-10). Additionally, improvements in 
Doppier indexes of left ventricular filling occur (11-13) be- 
cause left ventricular mass decreases after antihypertensive 
therapy. Left ventricular mass, even below partition values 
se!ected to define ieft ventricular hypertrophy, has been asso- 
ciated with cardiovascular risk independent of the magnitude 
of blrj,>d pressure elevation. Moreover, drugs equally e!?ec:i~ 
in redtilt& of blood preswre may differ in their ability to 
reduce ieft ventricular mass ($14) or to correct left ventricular 
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correlation 0.86), the 95% confidence interval widtb of :Y single 
replicate measurement of left ventricular mass was 59 g, exceeding 
usual decreases in mass during treatment. Study quality, which 
was dependent on age and wti& influenced test reliability. Al- 
tbough the confidence interval wiCth for ejection fraction was namw 
(5 U), those for peak early (E) and late (A) diastolic velocities were 
wide, resulting in a confidence inter& width for the E/A ratio of 1.5. 
(J Am Co11 Cardiol 1995;25:424-30) 
Conchsions. The temporal variability, particularly in obese or 
elderly patients, or both, of echocardiography for measurement of 
left ventricular mass precludes its use to measure changes in mass 
of the magnitude iikely to occur with therapy. Measurement 
stability is affected by study quality, and age and body weight both 
influence study quality. Although ejection fraction shoivs little 
temporal variability, the large width of the confidence interval of 
the Doppler E/A ratio impairs its use to serially measure diastolic 
function. 
hypertrophy. Hence, measurement of left ventricular mass and 
diastolic left ventricular function utilizing echocardiography 
may be of value in the cliniLdl monitoring of an!ihypertensive 
drug therapy in patients with hypertension. 
Estimation of left ventricular mass either from hvo- 
dimensional cross-sectional images (1.5-18) or from hvo- 
dimensional targeted M-mode (19-21) “ice-pick” views of the 
heart requires certain geometric assumptions and arithmetic 
manipulation of primary ectocaidiugraphic measurements. 
Nonetheless, these assumptions have in general been appro- 
priate in most clinical studies of h?lpertension, and echocardio- 
graphic techniques for measurement of left ventricular mass 
have been well validated by autopsy studies (17,19). 
However, the acquisition of echocardiograms is heavily 
operator interactive, requiring manual direction of the ultra- 
sound sector through the heart. Minor variation in acquisition 
technique may result in image planes that arc not consistent 
with the geumetric assumptions of left ventricular mass mea- 
surement or that produce images where obscure echocardio- 
graphic boundaries make measurement of left ventricular 
structures difficult. Hence, it is uncertain whether the value of 
echocardiography in showing clinical trial effects can be extrap- 
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olated to monitoring the effects of antihypertensivc therapy on 
left ventricular mass in individual patients. i?\dditionally. 
Dcppier indexes of diastolic left ventricular function are 
sensitive to alterations in heart rate, loading conditions and 
autonomic tone (22.-24) as well as minor differences in piace- 
ment of the Doppler sample volume id,. 
Therefore, we performed a simple replication reliability 
study within the context of a multicenter hypertension drug 
trial to determine the test-retest reliability of two-dimensional 
targeted M-mode echocardiography for the measurement of 
left ventricular mass, wall thickness and cavity size. In addition, 
we determined the test-retest reliability of commonly used 
Doppler indexes of diastolic function. The magnitude of 
change in measured variables necessary to exceed measure- 
ment and physiologic variability was determined and compared 
with changes in structural and functional variables reported in 
clinical trials of antihypertensive therapy utilizing echocardi- 
ography. 
Methods 
Patients. Ninety-six patients (mean age [tSD] 55 t 8 
years, range 24 to 78; 25 women, 71 men) with mild to moderate 
hypertension (diastolic blood pressure 95 to 110 mm Hg) 
recruited at 11 participating medical centers for a trial of the 
effects of drug therapy on left ventricular mass were the 
subjects for this study. Patients were excluded from participa- 
tion if at the local site the screening echocardiogram was 
considered to be of insufficient technical quality for the 
measurement of left ventricular mass or left ventricular inflow 
velocity on Doppler. Echocardiography was performed 6 
weeks after withdrawal of previous drug therapy and was 
repeated 6 2 8 days after th2 initial examination by the same 
technician utilizing the same uttrasonograph as that used in the 
initial echocardiogram. Of the 96 patients, 74 had echocardio- 
grams at both visits that were considered by the central 
echocardiography reading laboratory to be interpretable for 
left ventricular mass measurement; 78 had study pairs that 
were suitable for measurement of ejection fraction; and 88 had 
study pairs suitable for assessment of diastolic velocity on 
Doppler. 
E&ZZ!iG~i~pily. Training. Before the acquisition of 
study echocardiograms, a 2-day training meeting for partici- 
pating technician echocardiographers was conducted at the 
central echocardiography reading laboratory. During this 
meeting, technical and physiologic principles of echocardiog- 
raphy pertinent to quantitative applications of echocardiogra- 
phy in hypertension studies were reviewed. Additionally, the 
technician echocardiographers performed echocardiography in 
selected subjects under the direction of the central laboratory 
training staff to emphasize those aspects of echocardiogram 
acquisition pertinent to the quantitative requirements of the 
study. All sonographers had at least 3 years of previous clinical 
experience. 
Acquisition. After 6 to 12 weeks of withdrawal of previous 
antihypertensive therapy, two-dimensional targeted M-mode 
echucardiography was performed with the patient in the partial 
left lateral decubitus position. The Y-mode cursor was di- 
rected through the center of the two-dimensional parasternal 
short-axis image at or just distal to the tips of the mm-1 valve 
leaflets. Particular care was taken to achieve in ‘pe planes 
orthogonal to the left ventricular anatomic long axrs and to 
optimize definition of endocardial and epicardial interfaces. 
To ensure maximal recording of gray scale and sufficient 
M-mode image size, continuous strip chart recording on paper 
of derived M-mode was performed. 
Mitral inflow was sampled by placing the Doppler pulsed- 
wave sac,ple volume at the level of the mitral annulws with 
optimal adjustment of gain and filtration to achieve the 
acoustically purest frequency and narrowest spectral envelope 
obtainable. Becording was made on paper strip chart recording 
at 59 mm/s. 
fntetpretation. After comparability with the real-time two- 
dimensional echocardiographic parasternal images on video- 
tape was determined, M-mode paper strip chart recordings 
were analyzed utilizing a commercially available off-line anal- 
ysis system (Microsonics Datavue II) coupled to a digitizing 
tablet with a spatial resolwtion of 0.001 in. (0.0025 cm). 
Echocardiograms were encoded according to adequacy for 
measurement of the components of left ventricular mass as 
quality grade 1 if the study was minimally acceptable for 
measurement of left ventricular mass (i.e., nonoblique circular 
[eccentricity index cl.21 cross-sectional image in the paraster- 
nal short axis with placement of the M-mode cursor through 
the center of the left ventricle), as well as at least 5 mm of 
identifiable end-diastolic endocardial surfaces of the septum 
and posterior wall for ~3 beats that need not be contiguous. 
Grade 2 echocardiograms met the prevrous criteria as well as 
allowing identification of echocardiographrc interfaces for 
complete noncontiguous cycles. Grade 3 echocardiograms 
allowed identification of echocardiographic interfaces for mwl- 
tip!e series of at least three contiguous cycles. Grade 4 
echocardiograms met the previous criteria and were consid- 
ered optimal or near optimal for measurement. To minimize 
reader variability, all studies were interpreted by a single 
reader (S.L.). In addition, the echocardiograms of 30 randomly 
selected patients were interpreted in blinded manner by a 
second reader (J.S.G.) to determine whether temporal vari- 
ability in left ventricular mass measurement was similar for two 
readers. 
Measurement of ventricular septum, left ventricular cavity, 
posterior wall and left atrium were performed according to 
American Society of Echocardiography criteria (26). Left 
ventricular mass was calculated as described elsewhere (21). 
Left ventricwlar end-diastolic (EDV) and end-systolic (ESV) 
volumes were calculated as the cube function of the corre- 
sponding cavity dimensions (21). Ejection fraction was calcw- 
fated as (EDV - ESV)/EDV x 100 and expressed as dimen- 
sionless units. The peak velocity (E) of early diastolic filling 
was taken at the maximal excursion of the leading edge of the 
mitral time-velocity integral, and late diastolic peak filling rate 
(A) was determined from the maximal excursion of the time- 
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TaMe 1. Study Data 
95% Intraclass 
Percent Confidence Coeficient 
Study 1 Study 2 Average Absolute Error Intervai Linear of No. of 
(mean z SD) (mean It SD! Difference (?SD) (mean ?- SD) Width Correlation Correlation SEE Pts 
LiiDD (mm) 50.5 2 5.0 50.5 2 4.9 2.0 z 1.8 3.9 _+ 3.8 3.4 0.85 (0.81-0.90) 0.87 2.6 74 
LVDS (mm) 30.4 + 5.0 30.8 2 5.1 3.1 I3.4 10.4 2 13.7 4.9 0.76 (0.61-0.84) 0.76 3.3 75 
LVPW (mm) 12.2 ?. 2.0 12.1 _t 1.8 0.8 i 0.9 6.7 -t 1.4 1.7 0.80 (0.70-C.87) 0.79 1.9 74 
VS (mm) 12.6 + 2.1 12.5 f 2.0 0.7 -c 0.8 5.5 f 6.6 1.3 0.88 (0.82-0.92) 0.90 1.0 74 
u (mm) 41.8 9 .T.3 42.2 e 5.4 2.7 Lc 2.9 6.4 of 6.8 5.5 0.72 (0.61-0.81) 0.72 3.6 90 
LVDV (ml) 131.9 + 39.4 133.1 e 40.5 15.2 c 14.7 11.7 lr 1.2 29.2 0.86 (0.79-0.91) 0.86 20.2 Ul 
LVSV (ml) 30.6 + 15.6 32.0 c 15.9 8.8 f 8.9 2.9 t 7.7 16.01 0.73 (0.60-0.82) 0.73 10.7 15 
LVMI (dm’) 141 ? 34 139 r 31 14.9 2 12.8 11.1 f 10.0 27.2 0.82 (0.73-0.89) 0.82 19.6 74 
LVM (g) 323 2 82 320 k 77 27.1 k 27.1 11.4 t- 13.1 59.0 0.86 (0.78-0.91) 0.86 42.6 74 
EF units 77.2 t 1.8 77.4 c 1.7 2.4 -c 2.3 3.2 2 3.1 4.5 0.91(0.86-0.94) 9.91 3.3 78 
FS units 39.9 + 7.0 39.0 + 7.0 6.2 r 1.1 15.4 f 15.2 9.0 0.53 (0.35-0.68) 0.53 6.0 75 
E vel (cm/s) 53.1 2 15.9 53.7 + 14.3 9.4 i- 8.7 5.5 2 0.0 17.9 0.64 (0.50-0.75) 0.64 12.3 81 
A vel (cm/s) 59.1 2 15.1 60.0 C 15.3 9.6 2 8.1 16.2 rt 12.7 17.4 0.65 (0.51-0.76) 0.65 11.5 89 
E/A ratio 1.06 _t 1.11 0.94 2 0.31 0.29 f 1.1 20.1 f 22.8 1.5 0.26 (0.05-0.44) 0.12 1.09 89 
A vel (E vel) = Doppler peak late (early) diastolic velocity; EF = left ventricular ejection fraction; FS = left ven:ricular fractional shortening; LA = left atria1 
dimension on M-mode echocardiography; LVDD (LVDS) = left ventricular dimension at end-diastole (end systole); LVDV (LVSV) = left ventricular end-diastolic 
(end-systolic) volume; LVM = left ventricular mass; LVMI = left ventricular mass indexed to body surface area; LVPW = left ventricular posterior wall thickness; 
Pts = patients; VS = ventricular septal thickness in diastole. 
velocity integral with atria1 contraction. The average of 3 beats 
was used for all measurements. 
Intraobserver errors of 8.2%, 6.9% and 2.3% for septum, 
posterior wall and left ventricular diastolic dimension had 
previously been established for the reader from 35 studies of 
hypertensive patients read 1 to 2 weeks apart. Intraobserver 
errors for septum, posterior wall and left ventricular diastolic 
dimension determined from 56 echocardiograms from the 
current study, reread in blinded manner 18 to 24 months from 
the initial reading, were 9.1%, 8.9% and 2.6%, respective!y, 
similar to interobserver errors (comparison with reader J.S.G.) 
of 9.1%, 8.7% and 3.1%, respectively. For E and A peak 
diastolic velocities, the intraobserver errors were 8.7% and 
7.9%, respectively. The Pearson coefficient for intraobserver 
correlation of left ventricular mass was 0.82, diastolic dimen- 
sion 0.80, posterior wall 0.84, septal wall 0.83, E velocity 0.76, 
A velocity 0.86 and E/A ratio 0.79. There were no differences 
in observer error between echocardiograms of study quality 
grades 1 to 2 versus grades 3 to 4. 
Statistical methods. The measurements and computed val- 
ues analyzed are shown in Table 1. Correspondence of repli- 
cate measurements and calculated values were determined by 
calculation of the Pearson coefficient of correlation. 
Two statistical measures of reliability (27) for the sample 
population were used: the standard error of the measurement 
and the intraclass coefficient of correlation. Using a standard 
analysis of variance for a nested sample, the standard error of 
the measurement (SE) was computed (27), from which we 
derived the width of the 95% confidence interval for the true 
value of a measured or computed variable for a single subject, 
(i.e., 95% CI = rt1.96 SE/fi, where N = the number of 
replicate measurements). 
The intraclm coeflcient of correlation (rho) was calculated 
as rho = S,*/(S,* c S,*), where S,* = within-subject mean 
square and is a measure of the variance within subjects; S,* = 
(BMS - WMS)/K,,, where BMS = between-subject mean 
square, WMS = within-subject mean square, and Ka = number 
of replicate measurements, which in this case equals 2. Mea- 
surements that are highly reproducible for any given degree of 
intersubject variability will have values of the intraclass coef- 
ficient of correlation approaching +l. In an arbitrary classifi- 
cation scheme, intraclass coefficients in the range 0 to 0.20 = 
slight reliability, 0.21 to 0.40 = fair reliability, 0.41 to 0.80 = 
moderate reliability, and 0.81 to 1.00 = almost perfect reliabil- 
ity (26). The percent error was determined as the absolute 
average difference between measurements divided by the mean 
value of the measurements times 100. 
The independent contribution of age, echocardiographic 
study quality and body size (height and weight) to measure- 
ment variability was determined by stepwise multivariate re- 
gressior. analysis, where interstudy measurement difference 
was used as the dependent variable. Additionally, the relation 
of study quality to age, height and weight was determined by 
stepwise multivariable regression analysis. 
The statistical computer package SAS, versions 5 and 6, was 
used to generate the statistical analyses (29). All statistical tests 
were two-tailed, and p 5 0.05 was used to identify statistically 
significant results. For multivariate regression analyses, a sig- 
nificance level of 0.15 was required for entry into the model. 
Results 
Average values, absolute differences, percent error, widths 
of 95% confidence intervals of measurement change, linear 
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Figure 1. Test-retest comparison of values for 
left ver.tricular (LV) mass and its components: 
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and intraclass correlations are presented in Table 1. Computed 
average left ventricular mass and its measured components did 
not differ between studies (Table I), and the Pearson coeffi- 
cient of correlation (r = 0.86, p < 0.001) for left ventricular 
mass measurements (Fig. 1) repeated at 6 t 8 days after the 
initial study was not worse than that for interobserver (r = 
0.73) or intraobserver (r = 0.82) variability. Intraclass coeffi- 
cient of correlation for left ventricular mass was 0.86, within 
the range of “almost perfect reliability.” The S, for left 
ventricular mass was 30.2 g; hence, the width of the 95% 
confidence interval for a single replicate measurement of left 
ventricular mass was 59.0 g (1.96 S,). Of the components of left 
ventricular mass measurement, test-retest Pearson conela- 
tions (Fig. 1) were highest for septsi thickness (r = 0.88) and 
left ventricular diastolic cavity dimension (r = 0.85) but 
relatively modest (r = 0.80) for posterior wall thickness. For 
the components of left ventricular mass measurement, the 
intraclass coefticients of correlation of 0.88 and 0.90 for left 
ventricular diastolic dimension and ventricular septum, respec- 
tively, were also within the range of “almost perfect reliability.” 
The intraclass coe5cient of correlation of 0.79 for posterior 
wall was within the range of “moderate reliability.” 
Of the 30 randomly selected patients in whom serial 
echocardiograms were reread by a second observer, 29 had 
study pairs that were interpretable for left ventricular mass 
measurement. The intraclass coe5cient of correlation was 
0.90, and the width of the 95% confidence interval of 55.0 g was 
similar to the value of 59.0 g obtained from the larger cohort 
interpreted by the index reader. From intraobserver compari- 
sons of readings performed at wider time intervals, the 95% 
confidence width of 65.2 g was not less than that of temporal 
variability (59.0 g). 
Left ventricular function measurements. Ejection fraction 
was highly correlated (Table 1, Fig. 2) on test-retest compar- 
ison. Intraclass coe5cient of correlation (0.91) was within the 
Figure 2. Comparison of ejection fraction measured in same subjects 
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E Peak A Peak 
Figure 3. Test-retest comparison of values for early 
diastolic (E Peak) and late diastolic (A Peak) Doppler 
filling vcllocities. 
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range of “almost perfect reliability,” and the YS% confidence 
interval of change had a width of 4.5 U. However, linear and 
intraclass correlations of replicate determinations of E velocity 
and A velocity were poor (Table 1, Fig. 3) with wide confidence 
intervals for these measurements, particulariy for the calcu- 
lated E/A ratio. In contrast to left ventricular mass, the width 
of the 95% confidence interval (0,32) determined for intra- 
observer variability rvas substantially Izss than that (1.5) for 
temporal variability. 
Effects of study site, quality and age. There were no 
intercenter differences (analysis of variance, p = NS) in 
percent error of any echocardiographic measurement or in 
coded echocardiographic quality (average 2.9 + 1.1). However, 
echocardiograms with quality grades 1 to 2 had greater left 
ventricular mass error (18 f 11%) than did grade 3 to 4 studies 
(12 t 9%, p = 0.04). Moreover, the average study quality of 
2.5 2 1.5 for patients 240 years old (average 47 2 5, n = 24) 
was worse than study quality score (3.3 t 0.9, p = 0.007) for 
patients 545 years old (average 41 ? 3, n = 25). 
For patients ~40 years old, the width of the confidence 
interval for left ventricuiar mass was increased to 62.8 g, and 
the intraclass coefficient of correlation was decreased to 0.82. 
In contrast, fur patients 545 years old the width of the 
confidence interval for ieft ventricular mass was 46.4 g, and the 
intraclass coetlicient of ccrrelation was 0.91. 
@n strpwise multivariate regression analysis, the magnitude 
of difference in left ventricular mass berween sequential stud- 
ies was affected independently by study quality (p = 0.096, F = 
2.85), and height (p = 0.117, F = 2.52)-age and weight did 
not meet the 0.15 significance level tar entry into the model. 
Analysis of determinants of the magnitude of change in the 
components of left ventricular mass measurement showed that 
variation of left ventricular diastolic dimension was indepen- 
dently predicted by study quality (p = 0.040, F = 4.37) and age 
(p = 0.057, F = 3.75); height and weight did not meet criteria 
for entry into the model. For interstudy difference of left 
ventricular posterior wall and ventricular septum thickness, no 
variable met the 0.15 significance level for entry into the 
model. In turn, multiple regression analysis of the determi- 
nants of study quality showed that age (p = 0.043, F = 4.22) 
and weight (p = 0.098, F = 2.81) were both independently 
predictive; height did not meet the 0.15 significance level for 
entry into the model. 
Discussion 
Despite obtainirlg intraclass correlation within the rai;ge 
considered to represent excellent reliability, the width of the 
95% confidence interval for left ventricular mass change of 
59.0 g exceeds average decreases in left ventricular mass noted 
in echocardiographic studies of left ventricular mass regression 
with antihypertensive drugs. Because the width of the 95% 
confidence interval for left ventricular mass determined from 
tempozl variability is no less than that for intraobserver 
variability, physiologic variation and differences in echocardio- 
graphic acquisition technique are likely secondary in impor- 
tance to reader variability. 
Additionally, despite the importance of diastolic dysfunc- 
tion in the functional status of patients with hypertension, the 
reproducibility of peak early and late diastolic filling velocities 
was even worse than that of structural left ventricular mea- 
surements wiih echocardiography. In contrast to left ventricu- 
lar mass, physiologic or technical acquisition variability are of 
greater importance than reader variability, because the width 
of the 95% confidence limits of the E/A ratio are much less for 
intraobserver than temporal variability. 
In a meta-analysis of 109 published left ventricular mass 
regression studies comprising 2,357 patients (5), the average 
absolute reductions in left ventricular mass ranged from -21 g 
with diuretics (95% confidence interval [CI] -6 to -49 g) to 
-45 g with angiotensin-converting enzyme inhibitors (95% CI 
-23 to -66 g). Hence, in individual patients, the variabiiity of 
echocardiography for the measurement of left vzntricuiar mass 
would make it difficult to detect changes that could be expected 
during antihypertensive therapy. 
Moreover, relatively poor study quality, even in echocardio- 
grams that were considered to be readable, adversely affected 
the test-retest reliability for measurement of left ventricular 
mass, and age as well as weight were important determinants of 
poor study quality. Hence, in elderly or obese, or both, patients, 
and in other patients with echocardiograms considered techni- 
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tally suboptimal but still interpretable, the ability to detect clinical practice to permit its utilization to monitor left ven- 
treatment differences is even less. tricular mass in individual patients. 
Multicenter trials offer the advantage of larger numbers of 
patients and the possibility of more generalizable findings than 
might be obtained in single-center studies uf smaller numbers. 
However, it has been suggested (30) that homogeneity of 
echocardiography may be virtually impossible to obtain in 
multicenter studies, thus increasing the technical limitations of 
echocardiography in the measurement of left ventricular mass. 
In contrast, the present study shows that uniformity of study 
quality can be achieved in multicenter trials. Nonetheless, we 
documented that study quality is an important determinant of 
temporal variability in !eft ventricular mass measurement. 
Previous studies. The reproducibility of echocardiography 
for measurement of left ventricular mass has been studied 
utilizing a variety of study designs and statistical methods 
(16,31-35). Although important information has been gener- 
ated on interobserver and intraobsenrer variability, beat-by- 
beat variability and on the temporal (test-retest) variability in 
normal stmjects, the va’lue by which left ventricular mass must 
change to exceed methodologic variabilty on sequential exam- 
ination in hypertensive patients within a multicenter study has 
not been reported. On serial M-mode and two-dimensional 
echocardiographic evaluation in eight normal subjects (16) the 
mean difference for left ventricular mass over three serial 
examinations was 18.5 2 13 g, in contrast to 25 ? 23 g over two 
examinations in the present study. In another study (36) the 
standard deviation of repeat measurements of left ventricular 
mass in a single center study of normal subjects was 30 g, which 
would approximate 95% confidence intervals of 60 g for a 
single normal subject. 
Limitations of the present study. The study design differed 
from some aspects of clinical practice in that technicians 
performing the studies were specifically trained and monitored 
by a central laboratory in those facets of echocardiographic 
technique specific to acquisition of studies adequate for left 
ventricular mass determination. Moreover, to minimize tech- 
nical variability, the same technician, echo machine and reader 
were used for the initial and repeat examinations. However, 
these features might be expected to decrease temporal vari- 
ability. Hence, in clinical practice the 95% confidence interval 
of left ventricular mass might be even greater than 59 g. 
Advantages of the present study. The preseut study was 
designed to detect the variability of the complete “system” for 
left ventricular mass measurement by echocardiography, in 
which its components (i.e., patient, ultrasonograph, technician, 
image analysis unit, reader) were held constant during repeat 
testing over an interval in which true change in left ventricular 
mass was improbable. Several features of this study are con- 
sistent with clinical practice in that hypertension patients with 
a wide range of echo image quality, body weight and age were 
evaluated, rather than echogenic normal volunteers in whom 
smaller left ventricular mass and the likelihood of better image 
quality could result in underestimation of absolute variability 
of left ventricular mass. 
In contrast to previous work, the present study eva!uated 
patients with hypertension, many of whom had left ventricular 
hypertrophy. Moreover, patients were studied at multiple sites 
and were of varying echogenicity. 
Two-dimensional echocardiography may be more repro- 
ducible than M-mode for measuring left ventricular mass in 
normal subjects (16,34) and in patients with a distorted left 
ventricular contour (15j. However, it has not been demon- 
strated that two-dimensional echocardiography is superior to 
two-dimensional targeted M-mode echocardiography in the 
measurement of left ventricular mass in hypertension patients 
of varying echogenicity and in multiple centers where differ- 
ences in equipment and personnel may affect study quality. 
Difficulties in contouring the endocardium in still-frame im- 
ages, obtaining “true” long-axis measurements and in defining 
the epicardial border of the left ventricular free wall pose 
substantial difficulties to the use of hvo-dimensiona! echocar- 
diography for left ventricular mass measurement, particularly 
in patients who are not optimally echogenic. Hence, in one 
large multicenter study the feasibility and reliability of two- 
dimensional measurement of left ventricular mass was substan- 
tially less than that of two-dimensional targeted M-mode 
echocardiography (Gardin J, personal communication, Janu- 
ary 1994). It remains to be proved that the test-retest reliability 
of two-dimensional e&cardiography would be sufficient in 
Clinical implications. Although left ventricular hypertro- 
phy is an important pathophysiologic manifestation of hyper- 
tension, the cost of obtaining even yearly echocardiograms to 
monitor the effects of antihypertensive therapy would be 
enormous. The reported prevalence of left ventricular &per- 
trophy in patients with hypertension varies from 7% to 45% 
based on patient selection. Moreover, elevated left ventricular 
mass may confer risk even at values lower than the partition 
value selected to define left ventricular hypertrophy (8,9). 
Assuming an average cost for echocardiography of $50, 
obtaining an annual echocardiogram in -50 million Americans 
with hypertension to neasure left ventricular mass and follow 
up the effects of pharmacologic or nondrug therapy would 
translate to >$25 billion in annual costs. Even restricting 
echocardiography to an assumed 20% of patients with left 
ventricular hypertrophy would cost >$5 bZ!ion yearly. More- 
over, because left ventricular mass would have to decrease by 
~59 g, an amount generally greater than the decrease observed 
with antihypertensive therapy, two-dimensional targeted M- 
mode echocardiography would not be capable of detecting 
regression, or the lack thereof, of left ventricular hypertrophy. 
Although problematic for the evaluation of a small cohort, 
particularly in clinical practice where n = 1, echocardiography 
is still a useful technique in appropriately powered research 
studies. The width of a population confidence interval de- 
creases proportionately with the inverse of the square root of 
the sample size. Hence, although the confidence interval for 
change in left ventricular mass for a single patient is 59 g, in 50 
patients it would be 59 g/a or 8.4 g. 
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Other techniques for measurement of left ventricular mass. 
Studies of left ventricular mass utilizing magnetic resonance 
imaging (37-391 have shown that it has promise in substantially 
lowering the confidence limits of left ventricular mass mea- 
surement. Additionally, three-dimensional echocardiographic 
reconstruction may also provide comparable improvement 
(40). Hence, even though these may be more expensive at 
present than two-dimensional targeted M-mode echocardiog- 
raphy, their greater reproducibility may make them suitable for 
research studies where the greater cost could be offset by the 
savings from recruiting and studying fewer patients. 
Whether any technique should be used to monitor left 
ventricular mass as part of the clinical management of hyper- 
tension will depend not just on its accuracy but also on whether 
selection of a therapy based on reduction of left ventricular 
mass confers benefit over that achieved by effects on blood 
pressure and clinical factors such as carbohydrate tolerance or 
lipid metabolism. 
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